Bharat Biotech has submitted the trial data for children in the 2-18 years age group to the Drugs and Comptroller General of India (DCGI). The company’s...
In a statement, Bharat Biotech claimed that the Covaxin is overall 77.8 per cent effective against Covid, citing the data from the third phase of clinical...
India has begun the clinical trial of Bharat Biotech’s Covaxin on children. In a tweet, Prasar Bharati said that the testing is being done at the...
Recent Comments